La stagiaire participera à la conception d’encres pharmaceutiques pour l’impression 3D de comprimés mâchables destinés à l’usage pédiatrique. Cette nouvelle technologie permet de fabriquer de façon rapide et sécuritaire des imprimés gélifiés contenant une dose personnalisée d’un ou plusieurs médicaments. La stagiaire mettra au point de nouvelles formulations d’encres imprimables et en assurera la caractérisation, […]

This project will explore the use of virtual reality (VR) to reduce the need for sedative medication during breast surgeries performed under regional anesthesia. Currently, patients undergoing these procedures often receive intravenous sedative medication to ease anxiety, which can lead to complications like breathing problems or longer recovery times. VR immersion, which has already been […]

Ce projet vise à analyser l’impact de l’obligation réglementaire imposée par Santé Canada concernant la soumission des monographies de produit au format XML, en se concentrant sur une entreprise de taille moyenne : Mantra Pharma. Le projet analysera les processus actuels utilisé chez Mantra pour répondre à cette exigence, identifiera les obstacles rencontrés (techniques, humains, […]

People who use wheelchairs are at higher risk for weak bones because they aren’t putting pressure on their bones—something the body needs to keep bones healthy. When bones become fragile, even small accidents can lead to fractures, which may cause serious complications like infections, pain, longer hospital stays, and even depression. Unfortunately, many wheelchair users […]

The organization, GRAME (Groupe de recommandations et d’actions pour un meilleur environnement), is a Montreal-based environmental NGO leading participatory greening projects through its VIVRE (Ville Inclusive, Verte, Résiliente et Équitable) initiative. GRAME aims to mitigate climate vulnerability and environmental injustices in marginalized neighbourhoods by reducing urban heat islands, enhancing biodiversity, improving stormwater management, and increasing […]

)The research proposal is designed to examine the relationship between metabolism and the autonomic nervous system during exercise and recovery. This randomized, controlled crossover design experiment will consist of three sessions. The first session is a familiarization session. The second and third sessions will be the same, except the exercise portion will be done in […]

Global funding for life-sustaining therapy to treat HIV-1 has become unstable in recent years, particularly in sub-Saharan Africa, where 70% of the 37.9 million people with HIV (PWH) reside. Lifelong adherence to therapy is required as HIV integrates into the DNA of long-lived host immune cells, persisting quietly for decades with the potential to reactivate […]

We are developing a promising new technology based on extracellular vesicles (EVs, often referred to as exosomes), which are natural delivery vehicles produced by cells. These tiny particles have the potential to transform how we treat diseases by delivering therapeutic ingredients directly to where they’re needed in the body. To bring this technology to market […]

This project will develop a multi agent-based personalized healthcare platform that helps healthcare providers better understand and support people living with obesity. The tool will use artificial intelligence, large-language models to ask questions about a patient’s mental health, lifestyle, and quality of life, then use that information to suggest more tailored treatment options, such as […]

Ce projet de recherche vise à vérifier si un nouveau modèle épidémiologique développé par l’Agence canadienne des médicaments (ACM) est meilleur que le modèle actuellement utilisé, basé sur les demandes de remboursement, pour évaluer l’hypertension artérielle (HTA). L’HTA est un problème de santé courant au Canada, touchant environ une personne sur cinq. L’étude débutera par […]

Ce projet est axé sur l’élaboration d’un cadre méthodologique pour l’évaluation de la valeur thérapeutique et économique des médicaments orphelins dérivés du plasma dans un contexte de données limitées et ce, en vue du remboursement par les payeurs publics. La particularité des maladies rares est la population très restreinte qui est affectée. Ainsi, mener des […]

Chimera is a computational biotechnology venture that aims to develop a specialized CAR-T receptor design pipeline for ovarian cancer immunotherapy using deep-learning models to drastically reduce the candidate search space and experimental costs from the current standard where CAR-T receptor design costs millions of dollars. This grant will allow for initial computational validation of the […]